Business ❯ Healthcare Industry

Medical Devices

Robotic Surgery Robotic Systems Glucose Monitoring Diagnostic Tests Consumer Market Consumer Products Stereotaxis Organ Preservation Technology Startups Eye Care Companies Manufacturing Eye Care Products Fujirebio Diagnostics Glucose Monitoring Devices Medtronic Diabetes Technology Regulatory Compliance Market Dynamics Clinical Research Companies Investment Diabetes Management Ophthalmic Products Innovation Innovations in Medicine Regulatory Approvals Continuous Glucose Monitoring Systems Financial Challenges Continuous Glucose Monitors

FDA Authorizes Essilor’s Stellest Lens, First U.S. Spectacle Lens Shown to Slow Childhood Myopia

The De Novo authorization follows a U.S. randomized trial reporting a 71% average slowing of pediatric myopia over two years.

Erasmus Medical Center Performs First Procedures With Stereotaxis’ Genesis Robotic System

Mark Andrews Hosts First Nationwide Dexcom U Signing Day Camp in Baltimore

HHS Launches Major Wearable Tech Campaign Under Kennedy’s Health Initiative